Search Videos

Genomics for better health

Featuring speakers from GSK and the University of Oxford

Rare Disease as an Emerging Field of Medicine

Marshall Summar, Director, Rare Disease Institute, Children’s National Health System

Molecular diagnostics and the NHSE Long Term Plan for Cancer

Peter Johnson, National Clinical Director for Cancer, NHS England

How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum

Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement

Bringing the Benefits of Genomics to Everyone – Genomics England’s Efforts in 2022 and Beyond

Chris Wigley, Chief Executive Officer, Genomics England

Applications of RNA-seq for infectious disease research

Jose Afonso Guerra-Assuncao, Research Associate, UCL

The Future of Genomics: Health and Beyond

Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government

Mapping immune cells in tissues using single cell and spatial genomics

Sarah Teichmann, Cellular Genetics Programme Head, Wellcome Sanger Institute

Data Science as a Catalyst for Change: Lessons Learned from the Pandemic and Beyond

Andrew Morris, Director, HDRUK

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine

Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research

Translating germline cancer genomics into precision prevention of cancer

Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research

The Forefront of Genomics: Opportunities, Challenges, and Imperatives

Eric Green, Director, National Human Genome Research Institute (NHGRI)

Cancer evolution, immune evasion and metastasis

Charles Swanton, Senior Group Leader, Crick Institute

Advancing Genomic Medicine Through Global Collaboration and Data Sharing

Heidi Rehm, Chief Genomics Officer, Centre for Genomic Medicine and Co-Director, Medical and Population Genetics, Massachesetts General Hospital and Broad Institute

Spatial and temporal RNA-sequencing

Sam Rodriques, Group Leader, Francis Crick Institute

Combining long and short read sequencing

Andrew Beggs, Mike Hubank and Matt Loose

All of Us Research Program: Advancing Precision Health for All Populations

Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)

Liquid biopsy: From discovery to clinical implementation

Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf

UK Biobank: Going Beyond Genomics in 2022

Mark Effingham, Deputy Chief Executive Officer, UK Biobank